Epinephrine Versus Isoprenaline During Out-of-Hospital Cardiac Arrest With Asystole

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1178 participants.

Also called NCT06473116

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,178 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06473116
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06473116. Randomized; no masking; primary purpose treatment. Start 2025-03 (anticipated); primary completion 2029-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Epinephrine Versus Isoprenaline During Out-of-Hospital Cardiac Arrest With Asystole
Acronym
EPISO
Condition
Out-Of-Hospital Cardiac Arrest
Intervention (Drug)
Isoprenaline Only Product
Lead sponsor
University of Southern Denmark (class: other)
Collaborator
Odense University Hospital (class: other)

Record details

Record id
cardio:ct-nct06473116
Content hash
cb747dab4bf05a5685cbfa17ba8dd34d370e222a0fc9ec32b73ca54ff1ea558e